Avatrombopag for the treatment of children and adolescents with immune thrombocytopenia (AVA-PED-301): a multicentre, randomised, double-blind, placebo-controlled, phase 3b study.

Grace R. F., Leblebisatan G., Aydinok Y., Ünal Ş., Grainger J. D., Zhang J., ...More

The Lancet. Haematology, 2025 (SCI-Expanded)

• Publication Type: Article / Article
• Volume:
• Publication Date: 2025
• Doi Number: 10.1016/s2352-3026(25)00107-3
• Journal Name: The Lancet. Haematology
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, MEDLINE
• Istanbul University Affiliated: Yes